Int J Radiat Oncol Biol Phys 2015 Jul 15
A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High-Risk Prostate Cancer.
Related Questions
Do you also give neoadjuvant, concurrent, and adjuvant ADT in the same manner as for non-SBRT EBRT?
New answer by Medical Oncologist at Myo Thant, MD (July 29, 2023)
Will give ADT based upon current NCCN guidelines.